Study of Milnacipran for the Treatment of Fibromyalgia
Public ClinicalTrials.gov record NCT00314249. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Pivotal, Multicenter, Double-blind, Randomized, Placebo-Controlled Monotherapy Study of Milnacipran for the Treatment of Fibromyalgia.
Study identification
- NCT ID
- NCT00314249
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Forest Laboratories
- Industry
- Enrollment
- 1,025 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Milnacipran 100mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2006
- Primary completion
- May 31, 2008
- Completion
- Not listed
- Last update posted
- Jan 19, 2010
Started 2006
United States locations
- U.S. sites
- 24
- U.S. states
- 15
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site | Tuscaloosa | Alabama | 35406 | — |
| Forest Investigative Site | Fresno | California | 93710 | — |
| Forest Investigative Site | Pismo Beach | California | 93449 | — |
| Forest Investigative Site | Vista | California | 92083 | — |
| Forest Investigative Site | St. Petersburg | Florida | 33702 | — |
| Forest Investigative Site | St. Petersburg | Florida | 33709 | — |
| Forest Investigative Site | Stuart | Florida | 34996 | — |
| Forest Investigative Site | Atlanta | Georgia | 30328 | — |
| Forest Investigative Site | Springfield | Massachusetts | 01107 | — |
| Forest Investigative Site | Worcester | Massachusetts | 01610 | — |
| Forest Investigative Site | Omaha | Nebraska | 68134 | — |
| Forest Investigative Site | Haddon Heights | New Jersey | 08035 | — |
| Forest Investigative Site | Johnson City | New York | 13790 | — |
| Forest Investigative Site | Syracuse | New York | 13210 | — |
| Forest Investigative Site | Greensboro | North Carolina | 27408 | — |
| Forest Investigative Site | Cleveland | Ohio | 44122 | — |
| Forest Investigative Site | Columbus | Ohio | 43212 | — |
| Forest Investigative Site | Toledo | Ohio | 43623 | — |
| Forest Investigative Site | Eugene | Oregon | 97401 | — |
| Forest Investigative Site | Mechanicsburg | Pennsylvania | 17055 | — |
| Forest Investigative Site | Anderson | South Carolina | 29621 | — |
| Forest Investigative Site | Greer | South Carolina | 29651 | — |
| Forest Investigative Site | Richardson | Texas | 75080 | — |
| Forest Investigative Site | Virginia Beach | Virginia | 23454 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00314249, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 19, 2010 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00314249 live on ClinicalTrials.gov.